HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tiffany A Traina Selected Research

Fatigue

10/2022Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03).
12/2018Phase 2 Study of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Eribulin Mesylate With or Without Prophylactic Growth Factor for Adjuvant Treatment of Early-Stage Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
10/2011Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tiffany A Traina Research Topics

Disease

38Breast Neoplasms (Breast Cancer)
10/2022 - 06/2004
27Neoplasms (Cancer)
01/2022 - 10/2004
14Triple Negative Breast Neoplasms
04/2021 - 01/2010
6Disease Progression
11/2019 - 01/2010
5Prostatic Neoplasms (Prostate Cancer)
01/2022 - 06/2015
3Fatigue
10/2022 - 10/2011
2Neutropenia
10/2022 - 12/2018
2Nausea
12/2018 - 10/2011
2Carcinogenesis
07/2013 - 01/2010
1Mouth Neoplasms (Oral Cancer)
10/2022
1Exanthema (Rash)
08/2020
1Peripheral Nervous System Diseases (PNS Diseases)
12/2018
1Arthralgia (Joint Pain)
12/2018
1Confusion (Bewilderment)
08/2018
1Anemia
08/2018
1Delirium
08/2018
1Diarrhea
04/2016
1Hypersensitivity (Allergy)
04/2016
1Cognitive Dysfunction
06/2014
1Cough
10/2011
1Circulating Neoplastic Cells
10/2011
1Hyponatremia
10/2011
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
10/2011
1Dyspnea (Shortness of Breath)
10/2011
1Neoplasm Metastasis (Metastasis)
04/2010
1Hypertension (High Blood Pressure)
02/2010
1Headache (Headaches)
02/2010
1Proteinuria
02/2010
1Leukemia
02/2010

Drug/Important Bio-Agent (IBA)

12Hormones (Hormone)IBA
10/2022 - 06/2004
11Androgen Receptors (Androgen Receptor)IBA
01/2022 - 04/2009
10Estrogen ReceptorsIBA
01/2022 - 04/2009
6Progesterone Receptors (Progesterone Receptor)IBA
08/2017 - 04/2009
6Bevacizumab (Avastin)FDA Link
09/2011 - 11/2006
5Pharmaceutical PreparationsIBA
04/2021 - 04/2008
5AndrogensIBA
10/2017 - 07/2013
5Estrogens (Estrogen)FDA Link
08/2017 - 04/2009
5Capecitabine (Xeloda)FDA Link
01/2016 - 04/2008
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2010 - 04/2007
3ErbB Receptors (EGF Receptor)IBA
10/2022 - 12/2018
3Trastuzumab (Herceptin)FDA Link
11/2019 - 01/2012
3Paclitaxel (Taxol)FDA LinkGeneric
04/2016 - 04/2009
2palbociclibIBA
10/2022 - 01/2014
2PlatinumIBA
01/2021 - 06/2015
2human ERBB2 proteinIBA
11/2019 - 03/2016
2seviteronelIBA
08/2018 - 03/2016
2enzalutamideIBA
01/2018 - 08/2017
2Lapatinib (GW572016)FDA Link
04/2016 - 01/2012
2bicalutamide (Casodex)FDA LinkGeneric
03/2016 - 10/2013
2Biomarkers (Surrogate Marker)IBA
06/2015 - 07/2013
2Letrozole (Femara)FDA LinkGeneric
01/2014 - 02/2010
2Aromatase InhibitorsIBA
02/2010 - 06/2004
2Docetaxel (Taxotere)FDA Link
01/2010 - 04/2009
1Poly(ADP-ribose) Polymerase InhibitorsIBA
04/2021
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
04/2021
1B7-H1 AntigenIBA
04/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
08/2020
1AlpelisibIBA
08/2020
1Histamine H1 AntagonistsIBA
08/2020
1GemcitabineFDA Link
11/2019
1pertuzumabIBA
11/2019
1Taxoids (Taxanes)IBA
11/2019
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2018
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2018
1eribulinFDA Link
12/2018
1pegfilgrastim (Neulasta)FDA Link
12/2018
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2018
1Mitogen-Activated Protein KinasesIBA
10/2018
1LyasesIBA
08/2018
1Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA
08/2018
1CytochromesIBA
08/2018
1Anastrozole (Arimidex)FDA LinkGeneric
08/2017
1Fulvestrant (Faslodex)FDA Link
08/2017
1exemestane (Aromasin)FDA Link
08/2017
1Abiraterone AcetateIBA
03/2016
1ProgesteroneFDA LinkGeneric
03/2016
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2016
1Albumin-Bound PaclitaxelFDA Link
06/2015
1tigatuzumabIBA
06/2015
1Monoclonal AntibodiesIBA
06/2015
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
06/2015
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2012
1saracatinibIBA
10/2011
1EnzymesIBA
10/2011
1Epidermal Growth Factor (EGF)IBA
01/2011
1SteroidsIBA
01/2010
1Insulin-Like PeptidesIBA
12/2009
1Somatomedin Receptors (Somatomedin Receptor)IBA
12/2009
1ParaffinIBA
08/2009
1Formaldehyde (Formol)FDA Link
08/2009
1Eosine Yellowish-(YS) (Eosin)IBA
07/2009
1Hematoxylin (Haematoxylon)IBA
07/2009

Therapy/Procedure

24Therapeutics
10/2022 - 06/2004
10Drug Therapy (Chemotherapy)
04/2021 - 01/2008
2Lymph Node Excision (Lymph Node Dissection)
04/2010 - 07/2009
1Castration
08/2018
1Highly Active Antiretroviral Therapy (HAART)
07/2014
1Time-to-Treatment
10/2011
1Adjuvant Chemotherapy
07/2009